Page last updated: 2024-08-17

carbostyril and Psychomotor Agitation

carbostyril has been researched along with Psychomotor Agitation in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	26 (56.52)	29.6817
2010's	19 (41.30)	24.3611
2020's	1 (2.17)	2.80

Authors

Authors	Studies
Augustine, C; Brewer, C; Hefting, N; Hobart, M; Josiassen, MK; McQuade, RD; Sanchez, R; Skuban, A; Zhang, P	1
Caccia, F; Caloro, M; Cuomo, I; De Filippis, S; De Persis, S; Gentile, G; Girardi, P; Janiri, D; Kotzalidis, GD; Lionetto, L; Piazzi, G; Sciarretta, A; Simmaco, M; Simonetti, A; Telesforo, CL	1
Dowben, JS; Keller, DM; Keltner, NL; Myhre, KE	1
Charpeaud, T; Llorca, PM; Samalin, L	1
Eleméry, M; Faludi, G; Kovács, G; Szegő, A	1
Berman, RM; Hatch, A; Largay, K; Marler, SV; Nelson, JC; Sheehan, JJ; Stewart, TD	1
Howland, RH	2
McIntyre, RS; Weiller, E; Weiss, C; Zhang, P	1
Hsu, WY; Lane, HY; Lin, CH	1
Chen, L; Kinon, BJ; Kollack-Walker, S; Sniadecki, J; Stauffer, VL	1
Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Rappaport, SA	1
Coley, KC; Fabian, TJ; Lenze, EJ; Ruby, C; Scipio, TM	1
Kumar, R; Sachdev, PS	1
Maurer, I	1
Aman, MG; Carson, WH; Kamen, L; Manos, G; Marcus, RN; McQuade, RD; Owen, R	1
Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV	1
Ali, M; Assunção-Talbott, S; Carson, WH; Forbes, RA; Iwamoto, T; Nyilas, M; Pikalov, A; Robb, AS; Whitehead, R	1
Benedetti, AM; Frazee, LA; Leung, JG; Myers, N	1
Baker, RA; Docherty, JP; Eudicone, J; Mankoski, R; Marcus, RN; Mathew, S; McQuade, RD	1
Gagliardi, JP; Jiang, W; Muzyk, AJ; Revollo, JY; Rivelli, SK	1
Alsop, DC; Dazzan, P; Handley, R; Johnston, A; Kapur, S; Marques, TR; McGuire, P; Mehta, MA; O'Gorman, R; Pariante, CM; Reinders, AA; Taylor, H; Williams, S; Zelaya, FO	1
Bobmanuel, S; Davies, W; Dratcu, L; Farmer, A; George, M; Rana, T; Singh, M; Turner, M	1
Coffey, DB; John, N; Potter, PO	1
Adams, CE; Jones, H; Powney, MJ	1
Bienroth, M; Curtis, V; Debenham, M; George, M; Gonzalez, D; Jones, S; Pitsi, D	1
DeQuardo, JR	1
Engelhardt, E; Laks, J; Marinho, V; Miotto, R	1
Ballard, C; Waite, J	1
Duane, DD	1
Andrezina, R; Carson, WH; Iwamoto, T; Josiassen, RC; Manos, G; Marcus, RN; Oren, DA; Stock, E	1
Andrezina, R; Carson, WH; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E	1
Auby, P; Marcus, RN; McQuade, RD; Oren, DA; Sack, DA; Tran-Johnson, TK	1
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL	1
Crandall, DT; Gutierrez-Esteinou, R; Lau, GS; Marcus, RN; Marder, SR; Pikalov, A; Pultz, JA; West, B	1
Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Allen, MH; Crandall, DT; Currier, GW; Daniel, DG; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Crandall, DT; Gaulin, BD; Gutierrez-Esteinou, R; Marcus, RN; McQuade, RD; Pikalov, A; Pultz, JA; Sachs, GS; Sanchez, R	1
Allen, MH; Nordstrom, K	1
Breder, CD; Forbes, A; Marcus, RN; McQuade, RD; Mintzer, JE; Swanink, R; Tune, LE	1
Thone, J	1
Citrome, L	1
Amoretti, A; Di Lorenzo, R; Fiorini, F; Forghieri, M; Genedani, S; Rigatelli, M	1
Poyurovsky, M; Weizman, A; Weizman, R	1
Sanford, M; Scott, LJ	1

Reviews

9 review(s) available for carbostyril and Psychomotor Agitation

Article	Year
[Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?]. L'Encephale, 2014, Volume: 40, Issue:1 Topics: Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Hostility; Humans; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2014
Brexpiprazole for the treatment of schizophrenia. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:2 Topics: Antipsychotic Agents; Cognition; Dopamine; Humans; Psychomotor Agitation; Quinolones; Receptors, Dopamine D2; Schizophrenia; Serotonin; Thiophenes	2017
Akathisia and second-generation antipsychotic drugs. Current opinion in psychiatry, 2009, Volume: 22, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles	2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles	2012
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone	2006
Managing the acutely agitated and psychotic patient. CNS spectrums, 2007, Volume: 12, Issue:10 Suppl 1 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2007
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome	2007
Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder. CNS drugs, 2008, Volume: 22, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia	2008

Trials

18 trial(s) available for carbostyril and Psychomotor Agitation

Article	Year
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study. Current medical research and opinion, 2018, Volume: 34, Issue:4 Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Thiophenes; Treatment Outcome	2018
Intramuscular aripiprazole in the acute management of psychomotor agitation. Pharmacotherapy, 2013, Volume: 33, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hospitals, University; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2013
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis. Journal of affective disorders, 2014, Volume: 162 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Odds Ratio; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index	2014
Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials. Journal of affective disorders, 2016, Sep-01, Volume: 201 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Depressive Disorder, Major; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Quinolones; Serotonin Agents; Thiophenes; Treatment Outcome	2016
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Dopamine Antagonists; Double-Blind Method; Female; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Triglycerides; United States; Young Adult	2008
A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dementia, Vascular; Double-Blind Method; Drug Tolerance; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Placebos; Psychomotor Agitation; Quinolones; United States	2009
Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. Journal of psychiatric practice, 2009, Volume: 15, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia; Treatment Outcome	2009
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:11 Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Psychomotor Agitation; Quinolones; Self-Injurious Behavior; Treatment Outcome	2009
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data. Journal of child and adolescent psychopharmacology, 2010, Volume: 20, Issue:1 Topics: Administration, Oral; Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hostility; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Syndrome; Time Factors; Treatment Outcome	2010
Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia. Schizophrenia research, 2010, Volume: 120, Issue:1-3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Social Behavior Disorders; Young Adult	2010
Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Human brain mapping, 2013, Volume: 34, Issue:2 Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Blood Pressure; Brain Mapping; Cerebrovascular Circulation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Piperazines; Psychomotor Agitation; Quinolones; Receptors, Dopamine D2; Young Adult	2013
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology, 2006, Volume: 188, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Withholding Treatment	2006
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Current medical research and opinion, 2006, Volume: 22, Issue:11 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Treatment Outcome	2006
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:1 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia; Treatment Outcome	2007
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting	2007
Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:5 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Severity of Illness Index; Treatment Outcome	2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia	2007
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Institutionalization; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Severity of Illness Index; Treatment Outcome	2007

Other Studies

19 other study(ies) available for carbostyril and Psychomotor Agitation

Article	Year
Brexpiprazole (Rexulti) for agitation in Alzheimer's dementia. The Medical letter on drugs and therapeutics, 2023, 06-26, Volume: 65, Issue:1679 Topics: Alzheimer Disease; Antipsychotic Agents; Humans; Psychomotor Agitation; Quinolones; Thiophenes	2023
Biological perspectives: akathisia: ants in your pants. Perspectives in psychiatric care, 2013, Volume: 49, Issue:3 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Treatment Outcome	2013
[Emergency psychopharmacotherapy in Hungary -- preliminary data]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2014, Volume: 16, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clopenthixol; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Treatment; Female; Haloperidol; Humans; Hungary; Male; Middle Aged; Olanzapine; Piperazines; Practice Patterns, Physicians'; Promethazine; Psychiatry; Psychomotor Agitation; Psychotic Disorders; Quinolones; Surveys and Questionnaires	2014
Brexpiprazole: another multipurpose antipsychotic drug? Journal of psychosocial nursing and mental health services, 2015, Volume: 53, Issue:4 Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Humans; Psychomotor Agitation; Quinolones; Schizophrenia; Stress Disorders, Post-Traumatic; Thiophenes	2015
Aripiprazole for the treatment of agitation in persons with dementia? Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Dementia; Drug Labeling; Humans; Piperazines; Psychomotor Agitation; Quinolones; United States; United States Food and Drug Administration	2009
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Costs; Female; Haloperidol; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2011
A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:4 Topics: Aged; Aripiprazole; Cohort Studies; Female; Heart Rate; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies	2011
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:4 Topics: Acute Disease; Anhedonia; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Metabolic Diseases; Patient Participation; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Recovery of Function; Sexual Dysfunction, Physiological; Treatment Outcome	2012
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5 Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment	2012
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Tranquilizing Agents	2013
Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? The Journal of clinical psychiatry, 2004, Volume: 65, Issue:1 Topics: Anger; Antipsychotic Agents; Aripiprazole; Chronic Disease; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia	2004
Use of aripiprazole for psychosis and agitation in dementia. International psychogeriatrics, 2006, Volume: 18, Issue:2 Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Female; Humans; Neuropsychological Tests; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Treatment Outcome	2006
Atypical antipsychotics: special formulations for acute agitation. Journal of psychosocial nursing and mental health services, 2005, Volume: 43, Issue:10 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles	2005
Aripiprazole in childhood and adolescence for Tourette syndrome. Journal of child neurology, 2006, Volume: 21, Issue:4 Topics: Adolescent; Adolescent Behavior; Adult; Antipsychotic Agents; Aripiprazole; Attention; Body Weight; Child; Child Behavior; Cognition; Dose-Response Relationship, Drug; Humans; Male; Piperazines; Psychomotor Agitation; Quinolones; Tourette Syndrome; Treatment Outcome	2006
Intramuscular aripiprazole in the control of agitation. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:9 Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index; Surveys and Questionnaires	2007
Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Therapy, Combination; Humans; Male; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology	2007
Aripiprazole: effectiveness and safety under naturalistic conditions. Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:6 Topics: Adult; Antipsychotic Agents; Anxiety; Aripiprazole; Female; Humans; Inpatients; Italy; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Recurrence; Retrospective Studies; Schizoid Personality Disorder; Schizophrenia, Paranoid; Schizotypal Personality Disorder; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome	2007
Aripiprazole's receptor pharmacology and extrapyramidal side effects. The American journal of psychiatry, 2008, Volume: 165, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Piperazines; Piperidines; Positron-Emission Tomography; Psychomotor Agitation; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Urea	2008